Survival of Trial-Like and Non–Trial-Like Patients With Immunotherapy in Advanced Hepatocellular Carcinoma in Real World: A Collaborative Multicenter Indian Study (IMHEP) A Markov state-transition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results